China Shineway Pharmaceutical Group Limited (stock code: 02877) released its monthly return for the period ended 28 February 2026 on 02 March 2026. The total authorized share capital remained 5.00 billion ordinary shares at a par value of HKD 0.10 per share, translating into HKD 500.00 million in authorized capital.

No changes were recorded in the number of issued shares, remaining at 827.00 million. The company confirmed that it continues to meet the public float requirement, which stands at 25% of the total number of issued shares (excluding any treasury shares). No new issuances, share options, warrants, convertibles, or other share-related arrangements were reported during the period.